These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3900645)

  • 1. Characterization of pathogenic constituents of Cryptococcus neoformans strains.
    Kagaya K; Yamada T; Miyakawa Y; Fukazawa Y; Saito S
    Microbiol Immunol; 1985; 29(6):517-32. PubMed ID: 3900645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
    Levitz SM; DiBenedetto DJ
    J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of serum factors in the phagocytosis of weakly or heavily encapsulated Cryptococcus neoformans strains by guinea pig peripheral blood leukocytes.
    Ikeda R; Shinoda T; Kagaya K; Fukazawa Y
    Microbiol Immunol; 1984; 28(1):51-61. PubMed ID: 6374392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence of Cryptococcus neoformans serotypes A, B, C and D for four mouse strains.
    Irokanulo EA; Akueshi CO
    J Med Microbiol; 1995 Oct; 43(4):289-93. PubMed ID: 7562991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The defensive role of human pulmonary alveolar macrophages and polymorphonuclear leukocytes against a strongly or weakly virulent strains of Cryptococcus neoformans].
    Tabeta H; Kohno N; Kamei K; Honda A; Unno H; Nagao K; Yamaguchi T; Miyaji M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Sep; 29(9):1174-9. PubMed ID: 1753544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different susceptibility of three clinically isolated strains of Cryptococcus neoformans to the fungicidal effects of reactive nitrogen and oxygen intermediates: possible relationships with virulence.
    Xie Q; Kawakami K; Kudeken N; Zhang T; Qureshi MH; Saito A
    Microbiol Immunol; 1997; 41(9):725-31. PubMed ID: 9343824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased virulence in stable, acapsular mutants of cryptococcus neoformans.
    Fromtling RA; Shadomy HJ; Jacobson ES
    Mycopathologia; 1982 Jul; 79(1):23-9. PubMed ID: 6750405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans.
    Mody CH; Syme RM
    Infect Immun; 1993 Feb; 61(2):464-9. PubMed ID: 8423074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype A.
    Small JM; Mitchell TG
    Infect Immun; 1989 Dec; 57(12):3751-6. PubMed ID: 2680980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contributions to the strain-specific virulence of Cryptococcus neoformans. Animal experiments with two C. neoformans-strains isolated from bird manure. Preliminary report (author's transl)].
    Staib F; Mishra SK
    Zentralbl Bakteriol Orig A; 1975 Jan; 230(1):81-5. PubMed ID: 1101575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis.
    Yasuoka A; Kohno S; Yamada H; Kaku M; Koga H
    Microbiol Immunol; 1994; 38(11):851-6. PubMed ID: 7898383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virulence, capsule size and lipid composition interrelation of Cryptococcus neoformans.
    Upreti HB; Rawat DS; Das SK
    Microbiologica; 1984 Oct; 7(4):371-4. PubMed ID: 6392831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum.
    Steenbergen JN; Nosanchuk JD; Malliaris SD; Casadevall A
    Infect Immun; 2003 Sep; 71(9):4862-72. PubMed ID: 12933827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Cryptococcus neoformans variety gattii SOD2 reveals distinct roles of the two superoxide dismutases in fungal biology and virulence.
    Narasipura SD; Chaturvedi V; Chaturvedi S
    Mol Microbiol; 2005 Mar; 55(6):1782-800. PubMed ID: 15752200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phagocytosis of Cryptococcus neoformans by, and nonlytic exocytosis from, Acanthamoeba castellanii.
    Chrisman CJ; Alvarez M; Casadevall A
    Appl Environ Microbiol; 2010 Sep; 76(18):6056-62. PubMed ID: 20675457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic switching in a Cryptococcus neoformans variety gattii strain is associated with changes in virulence and promotes dissemination to the central nervous system.
    Jain N; Li L; McFadden DC; Banarjee U; Wang X; Cook E; Fries BC
    Infect Immun; 2006 Feb; 74(2):896-903. PubMed ID: 16428732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptococcus neoformans. 3. Inhibition of phagocytosis.
    Bulmer GS; Sans MD
    J Bacteriol; 1968 Jan; 95(1):5-8. PubMed ID: 4866104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.
    Granger DL; Perfect JR; Durack DT
    J Clin Invest; 1985 Aug; 76(2):508-16. PubMed ID: 3928681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenicity of Cryptococcus neoformans var. gattii in an immunocompetent mouse model.
    Torres-Rodríguez JM; Morera Y; Baró T; Corominas JM; Castañeda E
    Med Mycol; 2003 Feb; 41(1):59-63. PubMed ID: 12627805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis.
    Mylonakis E; Moreno R; El Khoury JB; Idnurm A; Heitman J; Calderwood SB; Ausubel FM; Diener A
    Infect Immun; 2005 Jul; 73(7):3842-50. PubMed ID: 15972469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.